SCHEMBL8570752

SCHEMBL8570752

CNC(=O)Cc1cccnc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.47
CYP2C9 P11712 1/20 0.45
NAMPT P43490 1/20 0.45
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.40
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
F2 P00734 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
FFAR1 O14842 1/20 0.38
MAPK8 P45983 1/20 0.38
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21617369 0.85 P2RX7 (0.58) P2RX7CYP2C9NAMPTKDM4ECYP1A2
SCHEMBL575046 0.80 KDM4E (0.62) P2RX7CYP2C9NAMPTKDM4ECYP1A2
SCHEMBL13568063 0.80 P2RX7 (0.47) P2RX7CYP2C9NAMPTKDM4ECYP1A2
SCHEMBL14678422 0.79 P2RX7 (0.47) P2RX7CYP2C9NAMPTKDM4ECYP1A2
Hydrochloric Acid SCHEMBL3725590 0.79 KDM4E (0.61) P2RX7CYP2C9NAMPTKDM4ECYP1A2
SCHEMBL999250 0.79 P2RX7 (0.50) P2RX7CYP2C9NAMPTKDM4ECYP1A2
SCHEMBL13731868 0.77 CYP2C9 (0.59) P2RX7CYP2C9NAMPTKDM4ECYP1A2
SCHEMBL19151081 0.77 CYP2C9 (0.52) P2RX7CYP2C9NAMPTLMNAF2
SCHEMBL8572812 0.76 KEAP1 (0.44) P2RX7CYP2C9KDM4ECYP1A2MAPT
SCHEMBL30421108 0.76 CYP2C9 (0.54) P2RX7CYP2C9NAMPTLMNAF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5846990-A Substituted biphenyl isoxazole sulfonamides BRISTOL-MYERS SQUIBB CO. (US) 1998-12-08 US claimed
US-20240238281-A1 PIPERAZINE DERIVATIVES AND APPLICATION THEREOF GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY (CN) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238281-A1 PIPERAZINE DERIVATIVES AND APPLICATION THEREOF AQP3, SLC6A7, ABCG2 P2RX7 356/4885CYP2C9 450/4885NAMPT 1511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.